Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NP90726l Tildrakizumab (Ilumetri(r))

The Common Services Agency (more commonly known as Public Service Delivery Scotland) (PSDS)

This public procurement record has 2 releases in its history.

Award

08 Sep 2026 at 13:00

Award Notice
Award

17 Mar 2026 at 16:34

Award Notice
Summary of the contracting process

The procurement covered the supply of tildrakizumab (Ilumetri®), a pharmaceutical medicine, to NHS Scotland. The buying organisation was the Common Services Agency, also known as Public Service Delivery Scotland, acting for NHS Scotland and its associated health bodies and Integrated Joint Boards. Delivery applied across Scotland to entities established under the National Health Service (Scotland) Act 1978 and Integrated Joint Boards established under the Public Bodies (Joint Working) (Scotland) Act 2014. This was a goods procurement for a framework agreement arranged as a single-supplier framework, with one framework participant appointed per line. The requirement was managed centrally for NHS Scotland rather than for one individual hospital or local health board.

The procurement is complete and has been awarded. It used a limited award procedure without a prior call for competition because the medicine was protected by exclusive rights, including intellectual property rights. Price was the evaluation criterion. Almirall Ltd received the awards and two active contracts were signed: one on 16 March 2026 for £844,250 and another on 27 March 2026 for £2,686,251, both in GBP. These figures are stated separately and are not combined here. The framework duration was 11 months, with two possible 12-month extension periods. The process received one bid, submitted electronically by a non-SME bidder from the EU. The tender was arranged as one lot, although that lot is recorded as cancelled while the related awards and contracts are active.

This opportunity shows demand from NHS Scotland for a branded, specialist pharmaceutical supplied through a centrally managed single-supplier framework. A credible competitor for a future requirement would need the legal ability to supply tildrakizumab (Ilumetri®) in the UK, including the relevant intellectual-property or exclusive-rights position, together with the regulatory, pharmaceutical distribution and supply-chain capability needed to serve NHS Scotland bodies across the country. The procurement also indicates that the buyer may use a restricted route where exclusive rights apply, rather than an open competition. Suppliers should therefore be able to evidence their rights to supply the named medicine, reliable national fulfilment, and the capacity to support a framework serving multiple Scottish public healthcare organisations.

How relevant is this notice?

Notice Information

Notice Title

NP90726l Tildrakizumab (Ilumetri(r))

Notice Description

Supply of Tildrakizumab (Ilumetri(r)) to NHS Scotland.

Lot Information

Lot 1

Supply of Tildrakizumab (Ilumetri(r)) to NHS Scotland. The Authority has awarded this framework as a single supplier Framework per line to one (1) Framework Participant.

Procurement Information

The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-066cb4
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/084864-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£3,530,501 £1M-£10M

Notice Dates

Publication Date
8 Sep 20264 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as Public Service Delivery Scotland) (PSDS)
Additional Buyers

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
1
Supplier Name

Almirall

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...